Research and Development

The Japan-based Eisai and Massachusetts-based Biogen have announced that experimental drug BAN2401 has demonstrated efficacy in slowing the progression of …

New evidence published in the British Journal of Surgery has indicated a troubling link between long-term use of the breast …

Jean-Yves Brault, Country Manager at Mylan UK, discusses how biosimilars are going to play an important role in driving down …

As the first week of July comes to an end we take a look over the most popular stories of …

As public focus on the issue of medicinal cannabis continues to grow, Zynerba Pharmaceuticals has announced that its transdermal tetrahydrocannabinol …

French pharmaceutical company Ipsen has announced that The New England Journal of Medicine has published the results of a Phase …

Biotechnology firm Abivax has lifted the curtain on new Phase 2a data for its HIV therapy ABX464, showing that the …

England’s Chief Medical Officer Dame Sally Davies has concluded that there is “conclusive evidence” that cannabis is medically beneficial for …

The state of Massachusetts has taken action to sue a board member at GlaxoSmithKline for her alleged role in fuelling …

The new July/August edition of Pharmafocus is now available to read online.

Researchers from John Hopkins University have developed an experimental drug that slows the progression of Parkinson’s disease in mice. The …

The Broad Institute of MIT and Harvard has expanded its partnership with Bayer through the launch of the Precision Cardiology …

The Danish pharmaceutical company Lundbeck has announced that the company’s Board of Directors have appointed Dr Deborah Dunshire as Lunbeck’s …

Manufacturing of pharmaceuticals takes place all over the world and the health of patients globally is at stake. Ben Hargreaves …

Roche has unveiled new Phase 3 data on its immunotherapy drug Tecentriq (atezolizumab) in combination with chemotherapy (Celgene’s Abraxane) as …